| Outcome Measures: |
Primary: Glucagon-like peptide-1 (GLP-1): Incremental and total area under the Concentration-Time Curve, Incremental and total area under the Concentration-Time Curve (AUC 0-240 min), -30, -15, 0, 10, 20, 30, 45, 60, 90, 120, 180, 240 min on study days 1-4 | Secondary: Responses of various other gut hormones: Incremental and total area under the Concentration-Time Curve, Incremental and total area under the Concentration-Time Curve (AUC 0-240 min), -30, -15, 0, 10, 20, 30, 45, 60, 90, 120, 180, 240 min on study days 1-4|Blood analysis of paracetamol as an assessment of gastric emptying, Assessment of gastric emptying, -30, -15, 0, 10, 20, 30, 45, 60, 90, 120, 180, 240 min on study days 1-4|Indirect calorimetry: Basal metabolic rate, Basal metabolic rate, -30 min to 240 min|Gallbladder volume as assessed by Ultrasound measurements, Gallbladder volume, -30 min to 240 min|Appetite as assessed by Visual analog scale score, Appetite, -30 min to 240 min
|
